NL-OMON38034已完成不适用
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET - THYROPET
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients with a history of differentiated thyroid cancer
- •2. After complete thyroidectomy and ablation of functional remnants with 131I.
- •3. Planned for blind high dose 131I treatment based on biochemically suspected recurrence, defined as a Tg-level above 2.0 ng/ml.
- •4. Ultrasonography of the neck performed < 2 months prior to inclusion.
排除标准
- •1. Age < 18 years
- •2. Pregnancy
- •3. Incapacitated subjects
- •4. Contrast enhanced CT performed < 4 months prior to inclusion
- •5. I-131 therapy performed < 12 months prior to inclusion
- •6. Indication for other therapy modality (ie. surgery in case of a positive ultrasonography, radiotherapy, embolization or chemotherapy)
研究者
相似试验
暂停
不适用
Improving the diagnostic strategy of patients with recurrent differentiated thyroid cancer with PET/CT.Differentiated thyroid cancerI-124 PET/CTFDG PET/CTNL-OMON27626The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital100
进行中（未招募）
不适用
Therapy with high activity of radioiodine in patients bearing differentiated thyroid cancerEUCTR2011-005248-81-ITISTITUTO NAZIONALE PER LA CURA TUMORI
招募中
不适用
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer PatientsDifferentiated Thyroid CancerNCT03757637National Taiwan University Hospital380
Unknown
不适用
PET Evaluation of Recurrent Differentiated Thyroid CancerThyroid NeoplasmsDifferentiated Thyroid CancerNCT01641679The Netherlands Cancer Institute100
尚未招募
不适用
Detection of thyroid cancer and central lymph node metastases using bevacizumab-IRDye800CW enhanced Molecular Fluorescence Guided Surgery1004373910014713thyroid cancerNL-OMON51075niversitair Medisch Centrum Groningen32